Skip to main content

Advertisement

SpringerLink
Log in

Interventional Pulmonologist Perspective: Treatment of Malignant Pleural Effusion

  • Head and Neck Cancer (J-P Machiels, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion Statement

The management of known malignant pleural effusions focuses around the initial thoracentesis and subsequent objective and subjective findings. A completely reexpanded lung after fluid removal and with symptomatic improvement predicts successful pleurodesis. Pleurodesis method depends on center expertise as well as patient preference. Medical thoracoscopy does not require the operating room setting and is performed on the spontaneously breathing patient with similar success rate to surgical thoracoscopy in the appropriately selected patients. However, it is not widely available. Talc insufflation is preferred for even distribution of sprayed particles to pleural surfaces. Most often, patients can be discharged home within 24 to 48 hours after continuous chest tube suction. Indwelling pleural catheter has become popular given the ease of insertion and patient centered home drainage. Coordinated care with good patient and family education and support is paramount to maximizing the beneficial potential of the catheter. Complications are minimal, and catheters are easily removed if patients can no longer benefit from drainage, or if pleurodesis has occurred. In the setting of trapped lung as a result of visceral pleura encasement from tumor, indwelling catheter can still be useful if the patient improves with thoracentesis. However, if no subjective improvement is seen after thoracentesis for trapped lung, then no procedure is recommended and other modes of palliation should be sought.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig 4

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Murray and Nadel's Textbook of Respiratory Medicine. 5th ed. Saunders, an imprint of Elsevier; 2010.

  2. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, et al. Management of malignant pleural effusions. Eur Respir J. 2001;18(2):402–19.

    Article  PubMed  CAS  Google Scholar 

  3. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 1977;63(5):695–702.

    Article  PubMed  CAS  Google Scholar 

  4. Hirsch A, Ruffie P, Nebut M, Bignon J, Chretien J. Pleural effusion: laboratory tests in 300 cases. Thorax. 1979;34(1):106–12.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Diagn Cytopathol. 1987;3(1):8–12.

    Article  PubMed  CAS  Google Scholar 

  6. Irani DR, Underwood RD, Johnson EH, Greenberg SD. Malignant pleural effusions. A clinical cytopathologic study. Arch Intern Med. 1987;147(6):1133–6.

    Article  PubMed  CAS  Google Scholar 

  7. Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer. 1985;56(4):905–9.

    Article  PubMed  CAS  Google Scholar 

  8. Leuallen EC, Carr DT. Pleural effusion; a statistical study of 436 patients. N Engl J Med. 1955;252(3):79–83.

    Article  PubMed  CAS  Google Scholar 

  9. Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest. 1975;67(5):536–9.

    Article  PubMed  CAS  Google Scholar 

  10. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol. 1987;31(2):85–97.

    PubMed  CAS  Google Scholar 

  11. Cohen S, Hossain SA. Primary carcinoma of the lung. A review of 417 histologically proved cases. Dis Chest. 1966;49(1):67–74.

    Article  PubMed  CAS  Google Scholar 

  12. Grossi F, Pennucci MC, Tixi L, Cafferata MA, Ardizzoni A. Management of malignant pleural effusions. Drugs. 1998;55(1):47–58.

    Article  PubMed  CAS  Google Scholar 

  13. Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J. 1997;10(8):1701–2.

    Article  PubMed  CAS  Google Scholar 

  14. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J. 1997;10(8):1907–13.

    Article  PubMed  CAS  Google Scholar 

  15. Bradshaw M, Mansfield A, Peikert T. The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion. Curr Oncol Rep. 2013;15(3):207–16.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  16. Miserocchi G. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J. 1997;10(1):219–25.

    Article  PubMed  CAS  Google Scholar 

  17. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Group BTSPDG. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65 Suppl 2:ii32–40.

    Article  PubMed  Google Scholar 

  18. Ruckdeschel JC. Management of malignant pleural effusions. Semin Oncol. 1995;22(2 Suppl 3):58–63.

    PubMed  CAS  Google Scholar 

  19. Tremblay A. Natural history of asymptomatic pleural effusions in lung cancer patients. J Bronchology. 2007;14(2):98–100.

    Article  Google Scholar 

  20. Sherman SC. Reexpansion pulmonary edema: a case report and review of the current literature. J Emerg Med. 2003;24(1):23–7.

    Article  PubMed  Google Scholar 

  21. Trachiotis GD, Vricella LA, Aaron BL, Hix WR. As originally published in 1988: reexpansion pulmonary edema. Updated in 1997. Ann Thorac Surg. 1997;63(4):1206–7.

    Article  PubMed  CAS  Google Scholar 

  22. Feller-Kopman D, Walkey A, Berkowitz D, Ernst A. The relationship of pleural pressure to symptom development during therapeutic thoracentesis. Chest. 2006;129(6):1556–60.

    Article  PubMed  Google Scholar 

  23. Cartaxo AM, Vargas FS, Salge JM, Marcondes BF, Genofre EH, Antonangelo L, et al. Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions. Chest. 2011;139(6):1424–9.

    Article  PubMed  Google Scholar 

  24. Shinto RA SD, Fischer CE, Light RW. Does therapeutic thoracentesis improve the exercise capacity of patients with pleural effusion? American Review of Respiratory Diseases. 1988;135(A244).

  25. Huggins JT, Doelken P, Sahn SA. The unexpandable lung. F1000 medicine reports. 2010;2:77.

  26. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer. 1974;33(4):916–22.

    Article  PubMed  CAS  Google Scholar 

  27. Rodriguez-Panadero F, Montes-Worboys A. Mechanisms of pleurodesis. Respiration. Int Rev Thorac Dis. 2012;83(2):91–8.

    Google Scholar 

  28. Lee YC, Baumann MH, Maskell NA, Waterer GW, Eaton TE, Davies RJ, et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest. 2003;124(6):2229–38.

    Article  PubMed  Google Scholar 

  29. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest. 2000;117(1):73–8.

    Article  PubMed  CAS  Google Scholar 

  30. Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc. 2008;83(2):235–50.

    Article  PubMed  Google Scholar 

  31. Dresler CM, Olak J, Herndon 2nd JE, Richards WG, Scalzetti E, Fleishman SB, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127(3):909–15.

    Article  PubMed  Google Scholar 

  32. Rodriguez-Panadero F, Segado A, Martin Juan J, Ayerbe R, Torres Garcia I, Castillo J. Failure of talc pleurodesis is associated with increased pleural fibrinolysis. Am J Respir Crit Care Med. 1995;151(3 Pt 1):785–90.

    Article  PubMed  CAS  Google Scholar 

  33. Hunt I, Teh E, Southon R, Treasure T. Using non-steroidal anti-inflammatory drugs (NSAIDs) following pleurodesis. Interact Cardiovasc Thorac Surg. 2007;6(1):102–4.

    Article  PubMed  Google Scholar 

  34. Haddad FJ, Younes RN, Gross JL, Deheinzelin D. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg. 2004;28(8):749–53. discussion 53-4.

    Article  PubMed  Google Scholar 

  35. Barbetakis N, Asteriou C, Papadopoulou F, Samanidis G, Paliouras D, Kleontas A, et al. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases. J Cardiothorac Surg. 2010;5:27.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest. 2001;120(1):19–25.

    Article  PubMed  CAS  Google Scholar 

  37. Villanueva AG, Gray Jr AW, Shahian DM, Williamson WA, Beamis Jr JF. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax. 1994;49(1):23–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  38. Sartori S, Tombesi P, Tassinari D, Ceccotti P, Nielsen I, Trevisani L, et al. Sonographically guided small-bore chest tubes and sonographic monitoring for rapid sclerotherapy of recurrent malignant pleural effusions. J Ultrasound Med: Off J Am Inst Ultrasound Med. 2004;23(9):1171–6.

    Google Scholar 

  39. Mager HJ, Maesen B, Verzijlbergen F, Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer. 2002;36(1):77–81.

    Article  PubMed  Google Scholar 

  40. Dryzer SR, Allen ML, Strange C, Sahn SA. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest. 1993;104(6):1763–6.

    Article  PubMed  CAS  Google Scholar 

  41. Goodman A, Davies CW. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer. 2006;54(1):51–5.

    Article  PubMed  Google Scholar 

  42. Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest. 2003;123(6):1895–8.

    Article  PubMed  Google Scholar 

  43. Yildirim E, Dural K, Yazkan R, Zengin N, Yildirim D, Gunal N, et al. Rapid pleurodesis in symptomatic malignant pleural effusion. Eur J Cardiothorac Surg: Off J Eur Assoc Cardiothorac Surg. 2005;27(1):19–22.

    Article  Google Scholar 

  44. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. The Cochrane database of systematic reviews. 2004(1):CD002916.

  45. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J cardiothorac Surg Off J Eur Assoc Cardiothorac Surg. 2006;29(5):829–38.

    Article  Google Scholar 

  46. Lee P, Sun L, Lim CK, Aw SE, Colt HG. Selective apoptosis of lung cancer cells with talc. Eur Respir J. 2010;35(2):450–2.

    Article  PubMed  CAS  Google Scholar 

  47. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120(1):56–64.

    Article  PubMed  CAS  Google Scholar 

  48. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest. 1994;106(2):342–6.

    Article  PubMed  CAS  Google Scholar 

  49. Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet. 1997;349(9047):251–2.

    Article  PubMed  CAS  Google Scholar 

  50. Davies HE, Lee YC, Davies RJ. Pleurodesis for malignant pleural effusion: talc, toxicity and where next? Thorax. 2008;63(7):572–4.

    Article  PubMed  Google Scholar 

  51. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004;170(4):377–82.

    Article  PubMed  Google Scholar 

  52. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. 2007;369(9572):1535–9.

    Article  PubMed  Google Scholar 

  53. Lee P, Colt HG. Pleuroscopy in 2013. Clin Chest Med. 2013;34(1):81–91.

    Article  PubMed  CAS  Google Scholar 

  54. Kiral H, Tezel C, Ocakcioglu I, Vayvada M, Bayram S, Urek S et al. One-Port Videothoracoscopic Surgical Intervention. Surgical laparoscopy, endoscopy & percutaneous techniques. 2014.

  55. Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Off J Eur Assoc Cardiothorac Surg. 2006;30(6):827–32.

    Article  Google Scholar 

  56. Gasparri R, Leo F, Veronesi G, De Pas T, Colleoni M, Maisonneuve P, et al. Video-assisted management of malignant pleural effusion in breast carcinoma. Cancer. 2006;106(2):271–6.

    Article  PubMed  Google Scholar 

  57. Arapis K, Caliandro R, Stern JB, Girard P, Debrosse D, Gossot D. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc. 2006;20(6):919–23.

    Article  PubMed  CAS  Google Scholar 

  58. Marrazzo A, Noto A, Casa L, Taormina P, Lo Gerfo D, David M, et al. Video-thoracoscopic surgical pleurodesis in the management of malignant pleural effusion: the importance of an early intervention. J Pain Symptom Manag. 2005;30(1):75–9.

    Article  Google Scholar 

  59. Brega-Massone PP, Lequaglie C, Magnani B, Ferro F, Cataldo I. Chemical pleurodesis to improve patients’ quality of life in the management of malignant pleural effusions: the 15 year experience of the National Cancer Institute of Milan. Surg Laparosc Endoscy Percutaneous Tech. 2004;14(2):73–9.

    Article  Google Scholar 

  60. Cardillo G, Facciolo F, Carbone L, Regal M, Corzani F, Ricci A, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg Off J Eur Assoc Cardiothorac Surg. 2002;21(2):302–5. discussion 5-6.

    Article  CAS  Google Scholar 

  61. Trotter D, Aly A, Siu L, Knight S. Video-assisted thoracoscopic (VATS) pleurodesis for malignant effusion: an Australian teaching hospital's experience. Heart Lung Circ. 2005;14(2):93–7.

    Article  PubMed  Google Scholar 

  62. de Campos JR, Vargas FS, de Campos WE, Cardoso P, Teixeira LR, Jatene FB, et al. Thoracoscopy talc poudrage : a 15-year experience. Chest. 2001;119(3):801–6.

    Article  PubMed  Google Scholar 

  63. Harris RJ, Kavuru MS, Rice TW, Kirby TJ. The diagnostic and therapeutic utility of thoracoscopy. A review. Chest. 1995;108(3):828–41.

    Article  PubMed  CAS  Google Scholar 

  64. Michaud G, Berkowitz DM, Ernst A. Pleuroscopy for diagnosis and therapy for pleural effusions. Chest. 2010;138(5):1242–6.

    Article  PubMed  Google Scholar 

  65. Yap KH, Phillips MJ, Lee YC. Medical thoracoscopy: rigid thoracoscopy or flexi-rigid pleuroscopy? Current opinion in pulmonary medicine. 2014.

  66. Bhatnagar R, Maskell NA. Medical pleuroscopy. Clin Chest Med. 2013;34(3):487–500.

    Article  PubMed  Google Scholar 

  67. Mineo TC, Sellitri F, Tacconi F, Ambrogi V. Quality of Life and Outcomes after Nonintubated versus Intubated Video-Thoracoscopic Pleurodesis for Malignant Pleural Effusion: Comparison by a Case-Matched Study. Journal of palliative medicine. 2014. While no randomized study of VATS vs. medical thoracoscopic pleurodesis exists, this retrospective case-matched study compared single-port VATS under general anesthesia/single-lung ventilation to medical thoracoscopy. The medical thoracoscopy group had equivalent pleurodesis outcome with less peri-operative morbidity/mortality and shorter hospitalization.

  68. Kolschmann S, Ballin A, Gillissen A. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions. Chest. 2005;128(3):1431–5.

    Article  PubMed  Google Scholar 

  69. Diacon AH, Wyser C, Bolliger CT, Tamm M, Pless M, Perruchoud AP, et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1445–9.

    Article  PubMed  CAS  Google Scholar 

  70. Zhang W, Wang GF, Zhang H, Mu XD, Jin Z. Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases]. Beijing da xue xue bao Yi xue ban. J Peking Univ Health Sci. 2008;40(6):600–2.

    Google Scholar 

  71. Lee P. Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes. Chest. 2012;142(1):15–7. discussion 20-1.

    PubMed  Google Scholar 

  72. Light RW. Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No. Chest. 2012;142(1):17–9. discussion 9-20.

    PubMed  Google Scholar 

  73. Yim AP, Chan AT, Lee TW, Wan IY, Ho JK. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg. 1996;62(6):1655–8.

    Article  PubMed  CAS  Google Scholar 

  74. Manes N, Rodriguez-Panadero F, Bravo J, Hernandez H, Alix A. Talc pleurodesis. A prospective and randomised study. Chest. 2000;118(4):131 s.

    Google Scholar 

  75. Terra RM, Junqueira JJ, Teixeira LR, Vargas FS, Pego-Fernandes PM, Jatene FB. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis? Chest. 2009;136(2):361–8.

    PubMed  Google Scholar 

  76. Xia H, Wang XJ, Zhou Q, Shi HZ, Tong ZH. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. PLoS One. 2014;9(1):e87060. This is the most up-to-date meta-analysis comparing chemical pleurodesis modalities and various sclerosants. Similar to the prior 2004 Cochrane meta-analysis, talc outcomes were more favorable than other sclerosants and VATS talc pleurodesis marginally outperformed bedside slurry. Limitations are described above in the body of the review.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Crnjac A, Sok M, Kamenik M. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma. Eur J Cardiothorac Surg: Off J Eur Assoc Cardiothorac Surg. 2004;26(2):432–6.

    Article  CAS  Google Scholar 

  78. Myers R, Michaud G. Tunneled pleural catheters: an update for 2013. Clin Chest Med. 2013;34(1):73–80.

    Article  PubMed  Google Scholar 

  79. Chee A, Tremblay A. The use of tunneled pleural catheters in the treatment of pleural effusions. Curr Opin Pulm Med. 2011;17(4):237–41.

    Article  PubMed  Google Scholar 

  80. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129(2):362–8.

    Article  PubMed  Google Scholar 

  81. Suzuki K, Servais EL, Rizk NP, Solomon SB, Sima CS, Park BJ, et al. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters. J Thorac Oncol. 2011;6(4):762–7. doi:10.1097/JTO.0b013e31820d614f.

    Article  PubMed  Google Scholar 

  82. Warren WH, Kalimi R, Khodadadian LM, Kim AW. Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg. 2008;85(3):1049–55.

    Article  PubMed  Google Scholar 

  83. Van Meter ME, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med. 2011;26(1):70–6.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Fysh ET, Wrightson JM, Lee YC, Rahman NM. Fractured indwelling pleural catheters. Chest. 2012;141(4):1090–4.

    Article  PubMed  Google Scholar 

  85. Efthymiou CA, Masudi T, Thorpe JA, Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters. Interact Cardiovasc Thorac Surg. 2009;9(6):961–4.

    Article  PubMed  Google Scholar 

  86. Qureshi RA, Collinson SL, Powell RJ, Froeschle PO, Berrisford RG. Management of malignant pleural effusion associated with trapped lung syndrome. Asian Cardiovasc Thorac Ann. 2008;16(2):120–3.

    Article  PubMed  Google Scholar 

  87. Thornton RH, Miller Z, Covey AM, Brody L, Sofocleous CT, Solomon SB, et al. Tunneled pleural catheters for treatment of recurrent malignant pleural effusion following failed pleurodesis. J Vasc Interv Radiol: JVIR. 2010;21(5):696–700.

    Article  PubMed  Google Scholar 

  88. Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA:J Am Med Assoc. 2012;307(22):2383–9. This is the first randomized trial comparing talc slurry pleurodesis and outpatient TPC insertion, as well as the first to choose a patient-centered primary outcome for MPE (mean daily dyspnea during initial 6 weeks). No difference in primary outcome was observed, but fewer patients in TPC group required further pleural intervention.

    Article  CAS  Google Scholar 

  89. Fysh ET, Waterer GW, Kendall PA, Bremmer PR, Dina S, Geelhoed E, et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012;142(2):394–400. In this prospective multicenter study of TPC vs. talc pleurodesis for MPE, TPC insertion was associated with fewer longitudinal hospital days and pleural procedures until death. No difference in rate of infection or protein depletion was observed.

    Article  PubMed  Google Scholar 

  90. Demmy TL, Gu L, Burkhalter JE, Toloza EM, D'Amico TA, Sutherland S, et al. Optimal management of malignant pleural effusions (results of CALGB 30102). J National Compr Cancer Netw: JNCCN. 2012;10(8):975–82.

    Google Scholar 

  91. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med. 1997;127(4):275–80.

    Article  PubMed  CAS  Google Scholar 

  92. Morel A, Mishra E, Medley L, Rahman NM, Wrightson J, Talbot D, et al. Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion. Thorax. 2011;66(5):448–9.

    Article  PubMed  Google Scholar 

  93. Fysh ET, Tremblay A, Feller-Kopman D, Mishra EK, Slade M, Garske L, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144(5):1597–602.

    Article  PubMed  Google Scholar 

  94. Reddy C, Ernst A, Lamb C, Feller-Kopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest. 2011;139(6):1419–23.

    Article  PubMed  Google Scholar 

  95. Tremblay A, Dumitriu S, Stather DR, Maceachern P, Illanes O, Kelly MM. Use of a drug eluting pleural catheter for pleurodesis. Exp Lung Res. 2012;38(9–10):475–82.

    Article  PubMed  CAS  Google Scholar 

  96. Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med. 2010;13(1):59–65.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Puri V, Pyrdeck TL, Crabtree TD, Kreisel D, Krupnick AS, Colditz GA, et al. Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg. 2012;94(2):374–9. discussion 9-80.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Penz ED, Mishra EK, Davies HE, Manns BJ, Miller RF, Rahman NM. Comparing Cost of Indwelling Pleural Catheter vs. Talc Pleurodesis for Malignant Pleural Effusion. Chest. 2014.

  99. Hsu LH, Soong TC, Feng AC, Liu MC. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2006;1(5):460–7.

    Google Scholar 

  100. Okur E, Baysungur V, Tezel C, Ergene G, Okur HK, Halezeroglu S. Streptokinase for malignant pleural effusions: a randomized controlled study. Asian Cardiovasc Thoracic Ann. 2011;19(3–4):238–43. Although a small randomized trial, it is the first and only to investigate intrapleural fibrinolytic therapy for loculated MPE. No adverse effects were reported in the fibrinolytic group, but increased fluid drainage and lung re-expansion provided a favorable pleurodesis environment.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Andrew J. Sweatt and Arthur Sung declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, USA

    Andrew J. Sweatt MD & Arthur Sung MD

Authors
  1. Andrew J. Sweatt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur Sung MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur Sung MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sweatt, A.J., Sung, A. Interventional Pulmonologist Perspective: Treatment of Malignant Pleural Effusion. Curr. Treat. Options in Oncol. 15, 625–643 (2014). https://doi.org/10.1007/s11864-014-0312-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-014-0312-6

Keywords

Search

Navigation